Treating to New Targets:Triglyceride and Residual Risk of Major CV Events
[Speaker] 김원/경희의대
Recent GLP-1 Receptor Agonist Cardiovascular Outcomes Trials: Heterogeneity and Similarities
[Speaker] 손장원/가톨릭의대
Discussion